|Bid||6,090.00 x 200|
|Ask||6,091.00 x 34100|
|Day's Range||6,009.00 - 6,135.00|
|52 Week Range||54.31 - 6,135.00|
|PE Ratio (TTM)||-997.22|
|Dividend & Yield||1.36 (7.11%)|
|1y Target Est||N/A|
Long-term investors take note, because bargains abound.
Everyone knows high prescription drug prices are a problem, but except for pharma stockholders, few people may realize that price cuts are rippling through the generic side of the industry.
Teva Pharmaceutical Industries’ business has undergone significant turmoil over the past two years, as its stock price clearly indicates. Teva (TEVA) was originally founded in 1901 as a wholesale drug distributor in modern-day Israel. By 2015, Teva was the world’s largest generic pharmaceutical manufacturer.